ENDRA Life Sciences (NDRA) Other Non-Current Liabilities (2024 - 2026)
ENDRA Life Sciences (NDRA) posted quarterly Other Non-Current Liabilities of $488604.0 for Q1 2026, up 1.85% quarter-over-quarter from $479747.0 in Q4 2025.
ENDRA Life Sciences (NDRA) Other Non-Current Liabilities (2024 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported Other Non-Current Liabilities for 3 consecutive years, with $488604.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Liabilities changed N/A year-over-year to $488604.0; the TTM figure through Mar 2026 stood at $488604.0 (changed N/A YoY), while the FY2025 annual figure was $479747.0, down 39.98% from the prior year.
- Other Non-Current Liabilities rose to $488604.0 in Q1 2026 per NDRA's latest filing, from $479747.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $799284.0 in Q4 2024 and bottomed at $479747.0 in Q4 2025.
- Historically, Other Non-Current Liabilities has averaged $590879.8 across 3 years, with a median of $542244.0 in 2025.
- On a YoY basis, Other Non-Current Liabilities climbed as much as 39.98% in 2025 and fell as far as 39.98% in 2025.
- ENDRA Life Sciences' Other Non-Current Liabilities stood at $799284.0 in 2024, then slumped by 39.98% to $479747.0 in 2025, then climbed by 1.85% to $488604.0 in 2026.
- Business Quant data shows NDRA's Other Non-Current Liabilities at $488604.0 in Q1 2026, $479747.0 in Q4 2025, and $595884.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn |
| 10 | ENDRA Life Sciences | 7.16 Mn | 1.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 555,306.00 |
| Mar 31, 2026 | 488,603.00 |
| Dec 31, 2025 | 479,747.00 |
| Sep 30, 2025 | 595,884.00 |
| Jun 30, 2025 | 328,610.00 |
| Mar 31, 2025 | 390,722.00 |
| Dec 31, 2024 | 799,284.00 |